Week of October 13 - 19, 2019


Atgam® (Anti-thymocyte Globulin [Equine])

Atgam® (Anti-thymocyte Globulin [Equine]) is used for a number of blood disorders, including aplastic anemia and Myelodysplastic Syndrome (MDS). It is also used to prevent the body from rejecting a kidney transplant, and in some cases, to prevent or treat Graft Versus Host Disease (GvHD).

Survivorship: Cancer After Cancer

In rare cases, some treatments for cancer can lead to a diagnosis of a second cancer at a later time. This is called secondary malignancy or secondary cancer.

Survivorship: Lung Health After Cancer

 It is important to do what you can to keep your lungs healthy and learn about possible symptoms of lung issues to report to your healthcare providers.

Respiratory Gating

An overview of respiratory gating, which involves certain breathing techniques used during radiation therapy. The most common types of respiratory gating are discussed.

Fedratinib (Inrebic®)

Fedratinib (Inrebic®) is a type of targeted therapy called a kinase inhibitor, used in the treatment of Myelofibrosis.

Entrectinib (Rozlytrek™)

Entrectinib (Rozlytrek™) is a kinase inhibitor used in the treatment of non small cell lung cancer and other solid tumors with certain neurotrophic receptor kinase (NTRK) genes.

Darolutamide (Nubeqa®)

Darolutamide (Nubeqa®) is an androgen receptor inhibitor used in the treatment of patients with non-metastatic, castration-resistant prostate cancer.

Blogs

The Conception of OncoLink – A Perspective
by Carolyn Vachani, MSN, RN, AOCN
March 1, 2012

“No Shave November”
by Angelo Melendez
November 10, 2016
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
R
S
T
U
V
X
Y
Z
#
 
A
B
C
E
F
G
H
K
L
M
N
O
P
R
S
T
U
V
 
 
Stay informed with the latest information from OncoLink!   Subscribe to OncoLink eNews
View our newsletter archives